We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Informatics

Informatics

Lonza

Lonza is a healthcare manufacturing organization helping pharmaceutical, biotech and nutrition companies to bring their treatments to market. They help their customers to deliver new and innovative medicines that treat a wide range of diseases, allowing their patients to benefit from life-saving and life-enhancing treatments.

Latest Content

Researchers conducting rapid sterility tests in a modern lab.

Lonza To Expand Bioscience Testing With Acquisition of Redberry

Lonza acquires Redberry to expand bioscience testing with rapid, high-precision microbiology solutions for pharmaceutical quality control.

Scientist working with lab automation equipment in a biopharma research facility.

Lonza To Expand Bioscience Testing Offering With the Acquisition of Redberry

Lonza will acquire Redberry, adding its Red One^™ rapid microbiology platform to accelerate pharma QC testing and product release.

3D rendering of an antibody-drug conjugate (ADC) molecule in a fluid environment for targeted therapy.

Lonza Receives Swissmedic Approval for Highly Potent Biologics Drug Product Filling Line in Stein (CH)

Lonza expands with a new GMP-approved aseptic filling line in Stein for highly potent biologics.

Blue abstract background showing microscopic cells, symbolizing cell therapy research.

Advancing Gene Editing for Next-Generation Immune Cell Therapies

Dr. Tobias Bexte will share recent advances that overcome key barriers to making NK cell therapies safe, effective and widely accessible.

Abstract blue background showing neural-like structures used in 3D cultures and organoid research

Innovative Approaches to Building Angiogenesis and Vascularized Systems

This webinar will share approaches for creating complex, vascularized models that better reflect human biology, enabling more predictive and meaningful results for disease research and therapeutic testing.

Using Human Co-Culture Models To Advance Preclinical Research

Attendees will gain insight into how these human cell-based models provide a more accurate representation of in vivo biology, and accelerate the development of safer, more effective therapies.

Enhancing Predictive Capabilities With Complex Human Cell-Based Models

This webinar will explore how primary human cells support drug discovery and preclinical pharmaceutical research, including toxicity and safety testing and analyzing the pharmacokinetics of new compounds.

Manipulating Human Cell Genetics for Cellular Therapies

In this webinar, Dr. Theo Roth will discuss how CRISPR-All can be used to push human genetics beyond their evolved functionality, enabling researchers to engineer synthetic cell states with therapeutic potential.

Abstract blue 3D shapes resembling biological cells under a digital overlay, symbolizing bioprocessing

Engineering Cell Models for Therapeutic Development and Screening

In this webinar, our expert speakers will explore how targeted integration techniques can significantly enhance the efficiency and reliability of engineering CHO cell models for drug discovery.

A capsule pill floating amid molecular structures and a DNA helix, symbolizing drug discovery and pharmaceutical innovation.

Drug Discovery: Innovations, Challenges and the Future of Medicine

This eBook explores the latest advancements in drug discovery, from AI-driven precision medicine to the promise and risks of new weight loss drugs.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter